GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BSP:BMYB34) » Definitions » Institutional Ownership

Bristol-Myers Squibb Co (BSP:BMYB34) Institutional Ownership : 0.00% (As of May. 23, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Bristol-Myers Squibb Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bristol-Myers Squibb Co's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Bristol-Myers Squibb Co Institutional Ownership Historical Data

The historical data trend for Bristol-Myers Squibb Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Institutional Ownership Chart

Bristol-Myers Squibb Co Historical Data

The historical data trend for Bristol-Myers Squibb Co can be seen below:

2020-06-30 2020-07-31 2020-08-31 2020-09-30 2020-10-31 2020-11-30 2020-12-31 2021-01-31 2021-02-28 2021-03-31
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01

Bristol-Myers Squibb Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Bristol-Myers Squibb Co (BSP:BMYB34) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (BSP:BMYB34) Headlines

No Headlines